Man Group PLC Eye Point Pharmaceuticals, Inc. Transaction History
Man Group PLC
- $37.2 Billion
- Q1 2025
A detailed history of Man Group PLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 14,509 shares of EYPT stock, worth $123,471. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,509Holding current value
$123,471% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
71.6MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$70.8 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$57.9 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$52.8 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$35.3 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$34.8 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $290M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...